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Sertoli cells are main players in the male gonads development and their study may
shed light on 46,XY disorders of sex development (DSD). Mature primary Sertoli cells
are incapable of proliferating in prolonged in vitro cultures and the available Sertoli
cell models have several limitations since they derive from mouse or human cancer
tissues. We differentiated human fibroblasts (HFs)-derived induced pluripotent stem cells
into Sertoli-like cells (SLC) and, in order to characterize this new Sertoli cell model,
we performed gene expression analyses by NextGeneration Sequencing techniques.
This approach revealed that our putative SLC have reduced expression of pluripotency
markers and expressed Sertoli cell markers such as SRY-Related HMG-Box 9 (SOX9),
vimentin (VIM), and claudin-11 (CLDN-11). More in detail, the transcriptional profile
analysis suggested that these cells are in an early stage of Sertoli cells maturation.
Harnessing the power of induced pluripotent stem cells, we were able to generate SLC
that show genetic and functional similarities to human Sertoli cells (HSerCs). SLC could
become an excellent source of patient-specific Sertoli cells that could be of paramount
benefit for both basic research and personalized medicine in sex development and
reproductive medicine.
Keywords: Sertoli cells, iPSC, NGS, reprograming, cell model, disorders/differences of sex development, DSD
INTRODUCTION
The normal development of a male individual depends on the development of a functional
testis where Sertoli cells (SCs) play a pivotal role. Failure of Sertoli cells function might result
in 46,XY disorders of sex development (DSD) with total or partial sex reversion or abnormal
production of spermatozoa during adulthood (Michala et al., 2008). One of the main obstacles
in the management of DSD is the lack of a correct understanding of their pathophysiology as the
causes of DSD are highly heterogeneous, with more than 60 genes reported by now to be associated
with sex determination and differentiation (Mendonca et al., 2009; Ono and Harley, 2013; Eid and
Biason-Lauber, 2016). The availability of specific cell models for the diverse variants might help to
better understand the mechanisms involved in human sex determination and development and to
implement more efficient treatments for DSD patients.
SCs are central players in the determination of the testis function as an endocrine (testosterone-
secreting) and reproductive (germ cells-producing) organ. SCs cells are the first cell type to
differentiate in the bipotential fetal male gonad, in turn enabling testicular cord formation and
controlling the differentiation and function of Leydig cells (Racine et al., 1998). Leydig cells, for
their part, secrete testosterone and therefore play important roles in downstream masculinization
events (Barsoum and Yao, 2010).
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SCs proliferate during two periods of life, in neonatal life and
in the peripubertal period. In the XY gonad, SCs proliferation
is initiated by the expression of the sex-determining region Y
chromosome gene (SRY), within the genital ridge (at 12.5 days
post-coitum in the mouse, Gubbay et al., 1990; and 6–9 weeks
after conception in humans, Bendsen et al., 2003). SRY lead
a series of signaling events and developmental processes that
ensure normal testis development. Expression of SRY-related
HMG-Box 9 (SOX9), a target of SRY, in gonadal somatic cells
is sufficient to induce the differentiation of SCs even in the
absence of SRY (Sekido et al., 2004). One morphologically
distinct event in testis development is the aggregation of the
SCs and primordial germ cells to form testicular cords. As the
cords develop, SCs attract endothelial cells from the coelomic
epithelium and from the mesonephros. Endothelial cells migrate
into the gonad and contribute to the characteristic male pattern
of vasculature (Combes et al., 2009; Cool et al., 2011). After
that, SCs become quiescent for a variable period depending on
the species (Sharpe et al., 2003), showing a second wave of
proliferation due to increased gonadotropins at puberty (Cortes
et al., 1987; Tarulli et al., 2012). The SCs maturation involves
changes in gene transcription and protein expression together
with the cessation of proliferation and the establishment of the
blood-testis barrier (BTB) (Table 1). Mature SCs are then capable
of sustaining spermatogenesis (Lucas et al., 2014). This dual
role of SCs highlights their importance in two critical events
separated by time and function: the sexual determination and
spermatogenesis.
One major hurdle in studying SCs is that mature SCs are
mitotically inactive, and primary immature SCs lose their unique
characteristics during prolonged culturing. Therefore, finding
an alternative source of these cells independent of donor testis
cells is of utmost interest both for basic research and clinical
applications.
Two main cell models were developed in this respect, the
TM4 and the NT2d1 cells. The mouse TM4 cell line was the
first Sertoli cell line established by passing cultures of immature
mouse SCs over many generations to generate an immortal line
(Mather, 1980). Nevertheless, murine models have demonstrated
to differ from humans in several genetics regulations involved
in sex determination and development such as SRY regulation
and MAPKs pathways (McClelland et al., 2011; Warr et al.,
2011; Larney et al., 2014). NT2d1 cells, in contrast, are human
pluripotent clonal cells derived from a testicular tumor (Andrews
et al., 1984) and have been shown to express the majority of
genes involved in mammalian sex determination (Barbara et al.,
1998). Due to their origin, these cell models are not ideal and have
limitations if compared with human functional SCs (McClelland
et al., 2011; Warr et al., 2011; Larney et al., 2014). Recently,
primary human Sertoli cells (HSerCs) have been considered for
human SCs studies (Chui et al., 2011; Jesus et al., 2016). Primary
HSerCs are supposed to be a reliable model of SCs but they are
unable to reproduce the phenotype of DSD patient’s SCs, their
collection is difficult and painful, and their expansion in culture
is very limited. Thus, an easy to obtain, patient-derived SC model
is necessary in order to study the patient-specific Sertoli cell
functionality.
Human induced-pluripotent stem cells (iPSCs) have been
developed as a powerful cell source for applications in
regenerative medicine and drug discovery, primarily based on
their extensive similarities to their human embryonic stem
cell counterparts and shared properties of self-renewal and
multilineage differentiation capabilities (Buchholz et al., 2009;
Burridge et al., 2012). iPSCs can be derived from somatic cells
via ectopic expression of transcription factors first identified by
Yamanaka and co-workers (Takahashi and Yamanaka, 2006; Yu
et al., 2007). In our quest to develop an in vitro human SC
model, we set to use iPSCs. To this end, we generated iPSCs from
terminally differentiated human fibroblasts (HFs) and guided
their differentiation into Sertoli-like cells (SLC) by the use of
the growth factors involved in Sertoli cells differentiation BMP4,
basic (b)FGF, prostaglandin D2 (PGD2), fibroblast growth factor
9 (FGF9) and activin A. The new SLCs were characterized by
using NGS analysis and compared with the currently available
models. Due to the reproducibility of the process and the
similarities observed with immature SCs, SLCs become an
exceptional source to build patient-specific SC models to study
the different DSDs.
MATERIALS AND METHODS
Cell Lines and Animals
Human foreskin fibroblast (HFFn, PC501 A-HFF, System
Biosciences Mountain View, CA, United States) were cultured in
DMEM medium supplemented with 10% FBS and 1% Pen/Strep
according to the manufacturer instructions.
NT2d1 embryonal carcinoma cells (NTERA-2 cl.D1,
American Type Culture Collection, Manassas, VA, United States)
were grown in DMEM supplemented with 10% FBS and 1%
Pen/Strep. NT2d1 RNA was sequenced and used as a Sertoli cell
model. Additionally, NT2d1 cells were also used as a feeder layer
for colonies differentiation by treating them with Mitomycin
C (MMC) to inhibit proliferation. Primary human Sertoli
cells (HSerC, ScienCell Research Laboratories, Carlsbad, CA,
United States) were cultured in poly-L-lysine coated flasks with
SerCM medium (ScienCell Research Laboratories, Carlsbad,
CA, United States) supplemented with 1% SerCGS (ScienCell
Research Laboratories, Carlsbad, CA, United States), 5%FBS
and 1% Pen/Strep according to the manufacturer instructions.
HEK293T cells (HCL4517, GE Healthcare, Buckinghamshire,
United Kingdom) were cultured in DMEM supplemented with
10% FBS and 1% Pen/Strep. SNL Feeder cells (CBA-136, Cell
Biolab, San Diego, CA, United States) were cultured in DMEM
supplemented with 10% FBS, 1% Pen/Strep and 0.1 mM MEM
Non-essential Amino Acids (NEAA), when a confluence of
about 96% was reached, SNL feeder cells were treated with MMC
and seeded in Matrigel coated plates as a feeder layer for HFs
de-differentiation.
NOD-SCID common gamma2- deficient (NSG) female mice
(University of Lausanne, Epalinges, Switzerland) were a kind gift
from Prof. Curzio Ruegg (University of Fribourg, Switzerland).
Eight weeks old animals were used for all in vivo teratoma
formation as proof of pluripotency. Animal experiments were
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TABLE 1 | List of genes from expressed in the different stages of differentiation and maturation of SCs based on literature search.
Symbol Description Cell stage Species Reference
SOX2 SRY-Box 2 PL Human Herreros-Villanueva et al., 2013
POU5F1 POU domain class 5, transcription factor 1 PL Mouse Avilion et al., 2003
DPPA2 Developmental Pluripotency Associated 2 PL Human, Mouse Kent et al., 1996; Madan et al., 2009; Friedmann-Morvinski
and Verma, 2014
DPPA4 Developmental Pluripotency Associated 4 PL Human, Mouse Kent et al., 1996; Madan et al., 2009; Friedmann-Morvinski
and Verma, 2014
NANOG Homeobox Transcription Factor Nanog PL Mouse Choi et al., 2012
NR0B1 Nuclear Receptor Subfamily 0 Group B Member 1 PRE Human, Mouse Hanley et al., 2000; Stevant et al., 2018
SRY Sex Determining Region Y PRE Human, Mouse Hacker et al., 1995; Hanley et al., 2000; Boyer et al., 2006;
Wilhelm et al., 2007; Stevant et al., 2018
AMH Anti-Mullerian Hormone ES Human Franke et al., 2004; Hero et al., 2012
FGF9 Fibroblast Growth Factor 9 ES Mouse Hanley et al., 2000; Kim et al., 2006; Stevant et al., 2018
CYP26B1 Cytochrome P450 Retinoid Metabolizing Protein ES Mouse McClelland et al., 2011
PTGDS Prostaglandin D2 Synthase ES Human, Mouse Malki et al., 2005; Moniot et al., 2009; O’Hara et al., 2015;
Stevant et al., 2018
SRC Proto-Oncogene Tyrosine-Protein Kinase Src ES Human Rajpert-De Meyts et al., 1999
KRT18 Keratin 18 ES Human Franke et al., 2004; Nicholls et al., 2012
DHH Desert Hedgehog ES Mouse Stevant et al., 2018
HSD17B3 Hydroxysteroid 17-Beta Dehydrogenase 3 ES Mouse Stevant et al., 2018
INHBB Inhibin Beta B Subunit ES Human Hero et al., 2012
CLDN11 Claudin 11 LS Human, Mouse Baccetti et al., 1998; Moroi et al., 1998; Hellani et al., 2000;
McCabe et al., 2016
AR Androgen Receptor LS Human Berensztein et al., 2006
FSHR Follicle Stimulating Hormone Receptor LS Human Baccetti et al., 1998
SOX9 SRY-Related HMG-Box 9 AS Human, Mouse Kent et al., 1996; Barbara et al., 1998; Hanley et al., 2000;
Stevant et al., 2018
VIM Vimentin AS Human Franke et al., 2004
WT1 Wilms Tumor 1 AS Mouse Stevant et al., 2018
GATA4 GATA Binding Protein 4 AS Human Ketola et al., 2000
PL, Pluripotent cell; PRE, Pre-Sertoli cell; ES, Early stage Seroli cell; LS, Late stage Sertoli cells; AS, All Sertoli cells.
carried out according to national ethical guidelines and
were approved by the veterinary service of Canton Fribourg
(2014_58_FR).
Reprogramming of HFs Into iPSCs
HFs reprogramming was performed by lentivirus transduction
based on Yamanaka and Thomson factors (Takahashi and
Yamanaka, 2006; Yu et al., 2007). Lentivirus production was
carried out using SIN4-EF2-O2S (Addgene plasmid # 21162)
encoding POU domain class 5, transcription factor 1 (POU5F1)
(also known as OCT4) and Sex Determining Region Y-Box 2
(SOX2), SIN4-EF2-N2L (Addgene plasmid # 21163) encoding
Homeobox Transcription Factor Nanog (NANOG) and Lin-28
Homolog (LIN28); and SIN4-CMV-K2M (Addgene # 21164)
encoding KLF4 and C-MYC. As packaging plasmids we used
MD2.G (Addgene plasmid # 12259), CMV (Addgene plasmid
# 8455), and PAX2 (Addgene plasmid # 12260). We included
a positive transfection control by adding CS-CG plasmid
(Addgene plasmid # 12154) encoding GFP (data not shown).
All plasmids were provided by Addgene (Cambridge, MA,
United States).
Infective particles were produced by transfection of HEK293T
cells. Lentiviruses were collected and HFs were infected 24 and
48 h after transfection. A day after the last transduction round,
HFs were seeded over a feeder layer of mitotically inactivated
SNL cells in gelatin pre-coated wells (Thermo Fisher Scientific,
Waltham, MA, United States) and medium was changed to
iPSC medium composed of F12 medium (Sigma-Aldrich, St.
Louis, MO, United States) supplemented with 10% Knockout
serum replacement (KSR, Gibco Laboratories, Gaithersburg, MD,
United States) to avoid any genotoxic effect (Rodríguez-Pizà et al.,
2010; Prakash Bangalore et al., 2017), 5% no essential amino acids
(NEAA, Gibco Laboratories, Gaithersburg, MD, United States)
1% 2-Mercaptoethanol, 5% penicillin/streptomycin and bFGF
(10 ng/ml). Medium was changed every day until small iPSC-
like colonies appeared. To check pluripotency in vivo, colonies
were stained with Alkaline Phosphatase Live (A 14353, Life
Technologies, Carlsbad, CA, United States) (Figure 1).
Teratoma Formation
Four different colonies were grown to confluency in 10 cm dishes,
harvested, spinned down, re-suspended in 40 µl DMEM/F12,
mixed with Matrigel (1:5) and kept on ice. Twelve female NSG
Mice (4–6 weeks old) were injected sub-cutaneously with the
cells/Matrigel mix. For each colony, three fractions were prepared
and injected in three different mice. The four colonies developed
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FIGURE 1 | Graphic representation of Human Fibroblasts (HFs) cell reprogramming and iPSCs differentiation toward SLCs. AP, alkaline phosphatase; EBs, embrioid
bodies; FGF9, fibroblast growth factor 9; IF, immunofluorescence; iPSCs, induced pluripotent stem cells; PGD2, prostaglandin 2; RNA-seq, next generation RNA
sequencing; SLCs, Sertoli-like cells; SNL, SNL feeder cells.
visible tumors in the mice, tumors were then resected and fixed
in paraformaldehyde (PFA).
Differentiation of iPSCs Into SLCs
iPSC colonies were picked by 10 mg/ml collagenase IV treatment.
Only colonies with no spontaneous differentiation spots were
selected and seeded in poly 2-hydroxyethyl methacrylate
(polyHEMA, Sigma-Aldrich, St. Louis, MO, United States)
coated ultralow attachment plates with iPSC Medium without
growth factors to form embryoid bodies (EBs) during 48–
72 h. To induce mesoderm commitment in the EBs, the iPSC
medium was supplemented with the specific growth factors bFGF
(50 ng/ml) and BMP4 (30 ng/ml) for 24 h. EBs were then
transferred to a MMC-treated NT2d1 feeder layer. Medium A
containing FGF9 (50 ng/ml) (Sigma-Aldrich, St. Louis, MO,
United States), PGD2 (1:2000) (Santa Cruz Biotechnolopy Inc.,
Santa Cruz, CA, United States) and activin A (40 ng/ml) (Gibco
Laboratories, Gaithersburg, MD, United States) was changed
daily until EBs spread flat into colony-like structures. Colonies
were re-suspended in medium A and seeded on Matrigel-coated
wells. The colonies reached confluence after a maximum of 12
days, when they were collected for qRT-PCR analysis.
qRT-PCR Analysis
qRT-PCR analysis was performed as described previously (Eid
et al., 2015). Briefly, extracted total RNA by Qiagen RNAeasy
plus (Qiagen, Hilden, Germany) was reverse-transcribed using
Omniscript reverse-transcriptase (Qiagen, Hilden, Germany)
according to the manufacturer instructions. All experiments were
performed on an ABI StepOnePlus Real-Time PCR (Thermo
Fisher Scientific, Waltham, MA, United States) and the PCR
products were quantified fluorometrically using the KAPA SYBR
FAST master mix (Roche, Basel, Switzerland). To normalize the
data, the mRNA level of cyclophilin was used.
RNA-Seq Analysis
RNA-sequencing data collection and analysis were carried out
by the Functional Genomic Center Zurich (Zurich, Switzerland).
Total RNA samples from NT2d1 triplicates, TM4 cell triplicates,
SLCs and HSerCs were analyzed by RNA-Sequencing on a
HiSeq 2500 Sequencer (Illumina, San Diego, CA, United States).
The reads were screened with FastQ Screen (Babraham
Bioinformatics) for possible contamination and a quality control
has been performed with FastQC (Babraham Bioinformatics).
RSEM (Dewey Lab) was used to quantify the gene expression
level and the differential expression between samples. The
corresponding false discovery rate (FDR), was calculated by
EdgeR (Bioconductor). The FDR is defined as the probability of a
false-positive discovery, taking into account the total number of
null hypotheses tested over the whole experiment. All differential
expressions with a FDR below 0.05 were defined as significant.
STAR (Spliced Transcripts Alignment to a Reference) was used
to map the RNA reads to the reference sequence. Sequencing data
are available at ENA repository under the ID PRJEB22617.
Immunofluorescence
Immunofluorescence was carried out as previously described (Eid
et al., 2010) Briefly, iPSC colonies, Matrigel-coated and ECM
3D gel cells were fixed in 4% paraformaldehyde in PBS and
permeabilized with 0.2% Triton X-100 in PBS. For pluripotency
assessment in iPSC colonies, cells were blocked in 3% BSA/PBS
for 1 h, washed 3 times in PBS and then incubated with primary
antibodies against OCT4 (1:200, BD Bioscience, San Jose, CA,
United States Cat# 611202), SOX2 (1:100, DSHB, Iowa City, IA,
United States Cat# ) TRA-1-81 (1:200) SSEA1 (MC-480), SSEA3
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(MC-631), and SSEA4 (MC-813-70) (1:3, deposited to the DSHB
by Solter, D., Knowles, B.B) overnight at 4◦C. For Sertoli-like
characterization, primary antibodies against SOX9 (Cat# MA5-
17177, Thermo Fisher Scientific, Rockford, IL, United States),
FOXl2 (Cat# LS-B12865, LifeSpan Bioscience), CLDN11 (Cat#
ab53041, Abcam, Cambridge, United Kingdom) were diluted
1:500 and incubated overnight at 4◦C.
Secondary antibodies Alexa Fluor 488 conjugated goat
anti-rabbit (Cat# A-11008), Alexa Fluor 594 conjugated goat
anti-mouse (Cat# A-11005) and Alexa Fluor 488 bovine anti-
goat (Cat# A-11055, Thermo Fisher Scientific, Rockford, IL,
United States) were diluted 1:1000 and incubated protected from
light for 1 h at room temperature. Mounting medium containing
DAPI (Vectashield, Burlingam, CA, United States) was added and
incubated for 20 min at room temperature before samples were
examined under immunofluorescence with a CKX41 inverted
microscope (Olympus Corporation, Tokyo, Japan).
Anti-Mullerian Hormone (AMH)
Quantification
Cells were incubated with equal amount of F-12 medium + 10%
Knockout serum replacement + 1% Pen/strep for a period of
2 h. After incubation, the medium was collected and centrifuged
at 1000x rpm for 20 min to discard cell debris. Remaining
cells were lysed in a cocktail of NP40 (AMRESCO LLC, Solon,
OH, United States), 1 mM PMSF (Thermo Fisher Scientific,
Waltham, MA, United States) and a cOmplete ULTRA protease
inhibitor tablet (Roche, Basel, Switzerland). The cells lysates
were used for total protein quantification by Bradford assay
(Bio-Rad Laboratories, CA, United States). Secreted AMH
protein was quantified by AMH ELISA kits (Cloud-Clone Corp,
TX, United States). Results were analyzed using an Infinite
microplate reader (Tecan Trading AG, Switzerland). Values were
standardized by the amount of total protein in the lysates.
Statistics
Quantitative variables are described as mean ± SD. A P < 0.05
was considered statistically significant. Unpaired t-tests were
performed using GraphPad Prism Software (La Jolla, CA,
United States).
RESULTS
HFs Are Reprogrammed to iPSCs
Induction of iPSCs by lentivirus transduction was performed
by following a reprogramming protocol as previously described
(Yu et al., 2007). Approximately 3 weeks post-transduction
we observed defined colonies that were flat and resembled
iPSC morphology: small, tightly packed cells with a high
nucleus/cytoplasm ratio (Kato et al., 2016). In vivo staining
with alkaline phosphatase (AP) live stain identified the colonies
as potential iPSCs (data not shown). Molecular and functional
characterizations were performed to confirm the pluripotency
of the colonies. The pluripotent cell markers POU5F1, SSEA3,
SSEA4, TRA-1-81, and SOX2 were markedly expressed in
our colonies whereas SSEA1, a marker of differentiation in
human stem cells could not be detected (Figures 2A,B). This
demonstrated that HFs were efficiently reprogrammed into iPSCs
colonies.
iPSC Colonies Are Capable of Generating
the Three Different Germ Layers
In order to assess if the generated iPSCs are able to differentiate
into the three germ layers, iPSCs were injected into SCID
mice that developed tumors 6 weeks post-injection. Tumors
were resected and fixed, and slide sections were examined by
microscopy for the formation of the three germ layers (teratoma).
Microscopic examination of the formed tumors showed that the
induced pluripotent stem cells we generated possess the ability to
differentiate into the three germ layers (Figures 2C,D).
After Differentiation Guidance From
iPSCs, SLCs Show a High RNA
Expression of Early Stage Sertoli
Markers When Compared to HSerCs and
NT2d1 Cells
The formation of embryoid bodies (EBs) is the main step in
the embryonic stem cells differentiation (Doetschman et al.,
1985). Colonies were successfully induced to form EBs by
culturing them in poly-HEMA-coated plates to prevent cell
attachment (Figure 3A). A second critical step is the mesoderm
commitment, where mesoderm layer is formed via epithelial-to-
mesenchymal transition (EMT) (Hay, 1995). iPSCs-derived EBs
were induced to mesoderm commitment by culturing them in
medium supplemented with BMP4 and bFGF. The differentiation
process was guided by a mixture of extracellular signaling
molecules that are known to induce Sertoli cell formation
in humans. These include FGF9, PGD2, BMP4 and (b)FGF
(Pellegrini et al., 2003; Schmahl et al., 2004; Moniot et al., 2009).
During the differentiation events, cells in the periphery of the
colonies changed their morphology to a multipolar, elongated
shape (Figures 3B,C). After 12 days in culture the colonies
reached confluency (Figure 3D).
In order to characterize our SLCs and compare them with
the available Sertoli cells models, we performed RNA-sequencing
analysis of SLCs derived from four colonies as well as NT2d1,
HSerCs, and iPSCs. The transcriptome analysis of 44949 genes
showed that RNA expression pattern was similar among SLCs
colonies and no significant differences were observed, suggesting
that the differentiation protocol is reproducible, the correlations
among each other were significantly high in all cases (R2 > 0.90)
(Figures 4A,B). When compared to the other cell lines analyzed,
SLCs clearly differed from HSerCs, NT2d1 cells or iPSCs
(Figure 4C).
Based on literature search from human and rodent sex
development studies (Hacker et al., 1995; Kent et al., 1996;
Baccetti et al., 1998; Hanley et al., 2000; Hellani et al., 2000; Ketola
et al., 2000; Franke et al., 2004; Sekido et al., 2004; Berensztein
et al., 2006; Boyer et al., 2006; Kim et al., 2006; Maldonado-
Saldivia et al., 2007; Moniot et al., 2009; Choi et al., 2012;
Hero et al., 2012; Jameson et al., 2012; Nicholls et al., 2012;
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FIGURE 2 | (A) Immunofluorescence staining of iPSC colonies. Zoom-in details in right-down squares. Cells were stained with antibodies against OCT4, TRA-1-81,
SSEA3, SSEA4, or SSEA1 and SOX2. Mounting medium contains DAPI stain. Pluripotency markers OCT4, TRA-1-81, and SOX2 positively marked the nuclei of
cells. SSEA3 and SSEA4 were localized in the cytoplasmic area of colonies. SSEA1 expression was absent in colony nuclei but observed in the feeder cells.
(B) RT-PCR analysis of pluripotential colonies for the genes DPPA2, DPPA4, ESG1, SOX2, and NANOG. Primers used for SOX2 and NANOG specifically detect
transcripts from the endogenous genes, but not from the lentiviral transgenes. Four (1–4) different colonies are shown. HF, terminally differentiated fibroblasts; iPSC,
induced pluripotent stem cells. (C,D) Teratoma formation analysis. Histology sections of teratoma stained with Hematoxylin & eosin. 1: mesoderm, 2: endoderm, 3:
ectoderm. Scale bars 50 µm for (A,C), and 100 µm for (D).
Herreros-Villanueva et al., 2013; Larney et al., 2014; McCabe
et al., 2016; Stevant et al., 2018), we selected a battery of 23 genes
involved in different stages of SCs differentiation and maturation
and analyzed their relative expression to iPSCS values for SLCs,
NT2d1 and HSerCs (Table 1 and Figures 5, 6).
We analyzed the gene expression pattern of SLCs in
comparison with HSerCs (Figure 5). Of the pluripotency markers
tested (SOX2, POU5F1, DPPA2, DPPA4, and NANOG), we
observed that DPPA2, DPPA4, POU5F1, and NANOG were less
expressed in SLCs than iPSCs. All the gene markers of all the steps
of Sertoli cell maturation (SOX9, VIM, WT1, and GATA4) where
highly expressed in HSerCs, as expected. However, SLCs only
shows high expression of SOX9 and VIM but not WT1 or GATA4.
Interestingly, when we looked at specific markers of immature
Sertoli cells (SRC, FGF9, AMH, CYP26B1, PTGDS, KRT18, DHH,
HSD27B3, and INHBB), SLCs showed elevated expression of
all of them but KRT18, this expression was remarkable in the
case of FGF9, AMH, CYP26B1, and PTGDS. In contrast, SLCs
showed a reduced expression of gene markers characteristic
for late stages of maturation (CLDN11, AR, and FSHR) when
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FIGURE 3 | Differentiation of embryoid bodies to Sertoli-like colonies.
(A) Embryoid bodies growing in suspension. (B) Embryoid body attached to
the plate bottom after been passed to an NT2d1 feeder layer. (C) Colony in
differentiation, the undifferentiated center can be appreciated while cells
around the borders have already changed their morphology. (D) Established
SLC colonies. Cells show an elongated shape similar to primary Sertoli cells.
Scale bar 100 µm for (A,C,D), and 50 µm for (B).
compared with HSerCs, this was especially clear for CLDN11,
a critical player in the formation of tight junctions (TJs) whose
maximum expression values correspond to the maturation of
Sertoli cell (Stammler et al., 2016). These data were validated by
qRT-PCR analysis (Supplementary Table S1 and Supplementary
Figure S2). Taken together, these results suggested that iPSCs
were successfully differentiated into SLCs and are indeed in an
early stage of Sertoli cell maturation. Thus, we considered SLCs
as an immature/differentiating Sertoli cell model, potentially very
useful to study developmental processes.
SLCs Express the Sertoli Cell Marker
Proteins SOX9, Claudin-11, and AMH
To test whether protein expression and localization in
SLCs are similar to natural Sertoli-cells, we performed
immunofluorescence for SOX9 (a Sertoli cell marker) (Kent
et al., 1996), and FOXL2 a granulosa cells marker that is not
expected to be expressed in a male lineage (a negative control)
(Cocquet et al., 2002). SOX9 was not expressed in HFs but
was present in the nucleus of all SLCs colonies, NT2d1, and
HSerCs (Figure 7). We also observed that SOX9 was consistently
expressed in SLCs even after freeze/thawing cycles, which suggest
a high stability of the model (data not shown). FOXL2 was
undetectable in all the colonies analyzed as well as the HSerCs
and HFs, but it was detected in KGN and NT2d1 cells at low
levels (Supplementary Figure S3).
Human Sertoli cells are known to express claudin-11 whose
expression is well conserved among different species and seems
FIGURE 4 | Colonies classification based on gene expression. (A) Transcriptome heatmap of genes expressed in the four colonies analyzed (C101, C103, C107,
C502). Red color means higher expression and blue color means lower expression than the average. Expression level represented as Fragments per Kilobase Million
(FPKM). (B) Colony-to-Colony correlation based on gene expression. Upper half of the chart represents scatter plot of all genes analyzed. Lower part represents the
correspondent R2. An R2 > 0.8 was considered significant. (C) Principal component analysis.
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FIGURE 5 | Analysis of genes markers of SCs stages. Transcriptome heatmap of relative gene expression between Sertoli cell models.RNA expression pattern for
NT2d1, HSerCs and four SLC colonies. Red color means high expression, blue color means low expression when compared to the mean expression level. n = 4 for
NT2d1 and SLCs, n = 2 for HSerCs and iPSCs.
essential for TJs formation (Stammler et al., 2016). Despite
the low expression of CLDN11 gene by SLCs, we analyzed
whether those levels were enough to form TJs by using
immunofluorescence analysis (Figure 8). Claudin-11 expression
was clearly detectable in SLCs colonies when cells interacted with
each other in tight groups. Upon comparison to the other cell
models, we observed that claudin-11 was distinctly located in
the membrane in SLCs and NT2d1 cells but its location was
much more diffuse in the case of HSerCs being predominantly
expressed in the cytoplasm. The presence and cellular location of
Claudin-11 in SLCs suggests that these cells resemble the natural
characteristics of HSerCs that are in the process of maturation.
AMH is a well-known marker of Sertoli cells. We tested
whether the high expression of the AMH gene we found in RNA-
Seq is reflected in a highly secretion of AMH protein by SLCs. We
quantified secreted AMH in the medium of SLCs by ELISA and
compared it with AMH secreted by both NT2d1 and HSerCs cell
lines as well as HFs. The levels of secreted AMH by SLCs were
indeed significantly higher than the AMH secretion of HSerCs or
NT2d1 cells (Figure 9).
DISCUSSION
SCs drive the development of the bipotential gonad toward
the male pathway and control proper testis function. The
small amount of cells collected in a biopsy together with the
impossibility of its prolonged culture prompted the search for
alternative cell sources to build a reliable model. Previous cell
models were obtained from mouse Sertoli cells (TM4 cell line)
or derived from human pluripotent carcinoma tissue (NT2d1
cell line). Mouse cell models like TM4 have shown differences
with human SCs in proliferation timing and protein expression.
Even when the use of commercially available HSerCs may help
to establish a model for healthy adult human SCs, they cannot
be used to mimic the particularities of the developing gonad
and identify mechanisms of disease in different developmental
defects like DSDs. Now, thanks to the power of novel cell
reprogramming technologies, we are able to reverse the cellular
faith of many different cell types to a pluripotent state. These
induced pluripotent cells have the ability to develop into almost
every cell type. We hypothesized that using this powerful tool
patient’s cells could be reprogrammed and re-differentiated into
SLCs, which may become a highly accurate model for the study
of SCs in DSD patients.
Human fibroblasts represent a suitable start-point for
reprograming methodology since they are terminally
differentiated cells that have no resemblance to pluripotent
characteristics or similarities with functional SCs. They also
constitute a reliable source of human cells and are easy cultured
in vitro. Moreover, mouse fibroblasts already proved to be
successfully reprogrammed into embryonic Sertoli cells (eSCs)
(Buganim et al., 2012).
iPSC colonies can be re-differentiated into other cell type
by forced expression of reprogramming factors via viral
transduction or by the addition to the medium of specific growth
factors in a very precise timing (Mummery et al., 2012; Yoder,
2015; Gunhanlar et al., 2017; Pandya et al., 2017) and the choice
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FIGURE 6 | RNA seq expression analysis of genes involved in the Sertoli cell differentiation. Comparison between NT2d1 cells (red), SLCs (green), and HSerCs
(blue). All values are relative to iPSCs expresion levels (dotted horizontal line). Additionaly to the expression of the general SC markes SOX9 and VIM, SLC showed
an elevated expresion of genes corresponding to early stages of differentiation and maturation of SCs (FGF9, AMH, CYP26B1, PTGDS, SRC, DHH, HSD17B3, and
INHBB). n = 4 for NT2d1 and SLCs, n = 2 for HSerCs and iPSCs. Colored bars and lines are mean ± SD. HSerCs, human Sertoli cells; NT2d1, NT2d1 cells; SLCs,
Sertoli like cells.
of these specific factors is crucial for successful differentiation. In
our case, (b)FGF, BMP4, FGF9, PGD2 and activin A are a very
well-known group of growth factors that induce differentiation
from embryonic stem cells (Schuldiner et al., 2000). (b)FGF and
BMP4 induce mesoendoderm signals of vital importance for the
formation of the urogenital system (Lawson et al., 1999; Evseenko
et al., 2010) and they stimulate the expression of SOX9. SOX9
plays a central role in Sertoli cell differentiation and its expression
needs to be maintained during the whole process. PGD2 and
FGF9 stimulate in an independent way the expression of SOX9
(Kim et al., 2006; Moniot et al., 2009). Additionally, Activin A
is essential for Sertoli cells early differentiation and proliferation
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FIGURE 7 | Immunofluorescence staining of SLC colonies with antibodies
against SOX9. Mounting medium contains DAPI stain. SOX9 were expressed
in SLC colonies. HF, terminally differentiated fibroblasts; HSerCs, human
Sertoli cells; NT2, NT2d1 cells; SOX9, SRY (sex determining region Y)-box 9.
Scale bars 50 µm.
(Nicholls et al., 2012). The consistent elevated expression of SOX9
in our SLCs is in consonance with an effective stimulation by all
the administered growth factors.
A comprehensive characterization of the transcriptional
landscape of our SCs based on the expression of differentiation
stage-specific markers is essential to determine the suitability of
the model. The transition from pluripotent cells to actual Sertoli
cells implies the reduction of expression of POU5F1, SOX2,
and NANOG, that act as intrinsic determinants of embryonic
stem cells (ESCs) identity (Nichols et al., 1998; Avilion et al.,
2003; Chambers et al., 2003). DPPA2 and DPPA4 were related
to the pluripotency network (Tung et al., 2013) and, even
when they are not essential for ESCs identity, seem to be
critical for early steps of embryogenesis (Madan et al., 2009).
The reduction in expression of these “pluripotency” genes
in SLCs compared to their expression in iPSCs denotes that
SLC model is advanced in the cell differentiation path. This
is of vital importance since the loss of those pluripotency
markers reduces the risk of spontaneous dedifferentiation
(Friedmann-Morvinski and Verma, 2014), making the model
more stable.
Male sex determination is triggered by the early expression
of SRY (Goodfellow and Lovell-Badge, 1993) followed by
its stimulation of SOX9. a pivotal sex-determining gene
and a milestone for checking the differentiation state of
SLCs. The clear expression of SOX9 denotes that our
SLCs were stably channeled toward the male determination
pathway.
The high expression tendency observed for the markers
PTGDS, FGF9, AMH, CYP26B1, and IHNBB (Figure 5 and
Supplementary Figure S1), suggested that SLCs colonies are
in early stage of maturation. PTGDS and FGF9 are expressed
during SCs differentiation shortly after SRY and SOX9 and
contributes to SOX9 nuclear translocation (Malki et al., 2005;
Kim et al., 2006; Wilhelm et al., 2007). CYP26b1 also acts
after SRY is expressed and reinforce the male differentiation
pathway by stimulating SOX9 and FGF9 (McClelland et al.,
2011). The elevated expression of SRC, which is involved in
the binding between SCs and germ cells and in the sperm
release (O’Hara and Smith, 2015) together with the observed
levels of INHBB and VIM suggest maturation, albeit again not
complete. AMH is routinely used as a marker for Sertoli cells
function during development and its production is known to
be triggered by SOX9 (among other factors). In accordance
to this, AMH expression and secretion was increased in SLCs
when compared to HSerCs in parallel to SOX9. It is also
known that the reduction of AMH expression levels likely
reflect SCs maturation (Hero et al., 2012) and matches the fact
that SCs maturation involves the loss of expression of fetal
markers after puberty (Rajpert-De Meyts et al., 1999). Taken
together, these results suggest that our cells are indeed in an
intermediate state of differentiation/maturation while HSerCs
show a more advanced maturation phenotype. In the gonads,
AMH is produced as an inactive pro-protein (proAMH) which
is folded in its C-terminus. Pro-AMH is cleaved in a later stage
by serine protease into two different fragments linked to each
other (McLennan and Pankhurst, 2015). Although speculative,
this higher total AMH secretion in SLCs may be explained
by post-translational modifications of pro-AMH or its active
form, preventing the protein degradation and promoting its
accumulation in the medium. Interestingly, NT2d1 cells showed
higher AMH gene expression than SLCs but significantly lower
protein secretion, suggesting that AMH secreted protein is more
stable in SLCs than NT2d1 cells.
Another critical feature of mature SCs is the creation and
maintenance of the BTB and their relations with the basement
membrane, a modified form of extracellular matrix (ECM).
Proteins in the ECM were shown to regulate BTB dynamics
via the interactions between collagens, proteases and protease
inhibitors. It was postulated that ECM regulates Sertoli cell tight-
junctions barrier function and spermatogenesis via integrins,
which in turn transmit signals to regulate junction dynamics (Siu
et al., 2003). The BTB is maintained thanks to the tight-junctions
between mature SCs, preventing the entrance of molecules
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FIGURE 8 | Immunofluorescence staining of SLC colonies with antibodies against CLDN11. Mounting medium contains DAPI stain. Claudin-11 was expressed in
SLCs as in NT2d1 and HSerCs. Upper right squares show a magnification detail of the original pictures. CLDN11, claudin-1; HSerCs, human Sertoli cells; NT2d1,
NT2d1 cells; SLCs, Sertoli like cells. Scale bars 50 µm.
FIGURE 9 | Secreted AMH quantification by ELISA. SLCs secreted AMH
levels were significantly higher when compared with AMH secretion by
HSerCs or NT2d1 cells. HF: terminally differentiated fibroblasts, HSerCs:
primary human Sertoli cells, NT2d1: NT2d1 cells, SLCs: Sertoli like cells. n = 4
for SLCs and HSerCs, n = 2 for HFs and NT2d1. ∗P < 0.05, ∗∗P < 0.01,
∗∗∗∗P < 0.0001.
to luminal space of the seminiferous tubules. Occludins and
claudins are common elements of the TJs in several species but
only claudin-11 expression is well conserved among mouse, rat
and human, emphasizing its essential role in the BTB structure
(Stammler et al., 2016). In rodents, claudin-11 has shown to
be regulated by FSH and testosterone and plays a key role
in the formation of the SCs TJs, with maximal expression
corresponding to the creation of the BTB (Hellani et al., 2000).
In humans, claudin-11 presence is almost exclusive of Sertoli
cells (and oligodendrocytes in the central nervous system) (Moroi
et al., 1998; McCabe et al., 2016). Accordingly, expression levels
of CLDN11 were high in HSerC, indicating their mature state.
Since the levels of CLND11 in SLCs were lower we tested whether
the protein levels were enough to form proper TJs. The presence
of claudin-11 in SLCs junctions suggested that our SLC model
is indeed in the process of maturation, being able to create
cell-to-cell connections in the same way that natural human
SCs do. This ability is of great interest to study co-cultures
with other testicular cells types like spermatogonia or myoid
cells.
CONCLUSION
We were able to reprogram and re-differentiate terminally
differentiated HFs into SLCs. This new SLC model resembles
human SCs in morphology and gene expression. Furthermore,
our model showed protein expression of human SCs markers
like SOX9, VIM, SRC and Claudin-11, making them a reliable
model for human SCs. From a more clinical point of view,
given the difficulties to recapitulate the human phenotype using
classical animal models, these results offer the opportunity to
generate patient-specific SCs models that, together with the
novel techniques in next generation sequencing, will allow
the study of mechanism of disease for single patients and
may boost the understanding of the individual complexities
and help to refine the aim of treatments for human DSDs.
Furthermore, knowledge acquired by studying rare diseases
might help clarify the still unknown pathophysiology of more
common and complex entities such as male in- and decreasing
fertility.
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